Review article · 2014 · Open access
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
Schizophrenia Bulletin, 41(4), 892–899 · Published 20 December 2014 · DOI 10.1093/schbul/sbu170
In brief
“Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials” is a 2014 review article by Paolo Fusar‐Poli and 6 co-authors, published in Schizophrenia Bulletin. OpenAlex counts 782 citations as of 20 November 2026. It is open access: the full text is free to read at Schizophrenia Bulletin.
- Citations
- 782
- Most cited in
- 2020 (95)
- Field-weighted impact
- 4.49
- References
- 67
- Authors
- 7
Abstract
OBJECTIVES: Existing treatments for schizophrenia can improve positive symptoms, but it is unclear if they have any impact on negative symptoms. This meta-analysis was conducted to assess the efficacy of available treatments for negative symptoms in schizophrenia. METHODS: All randomized-controlled trials of interventions for negative symptoms in schizophrenia until December 2013 were retrieved; 168 unique and independent placebo-controlled trials were used. Negative symptom scores at baseline and follow-up, duration of illness, doses of medication, type of interventions, and sample demographics were extracted. Heterogeneity was addressed with the I (2) and Q statistic. Standardized mean difference in values of the Negative Symptom Rating Scale used in each study was calculated as the main outcome measure. RESULTS: 6503 patients in the treatment arm and 5815 patients in the placebo arm were included. No evidence of publication biases found. Most treatments reduced negative symptoms at follow-up relative to placebo: second-generation antipsychotics: -0.579 (-0.755 to -0.404); antidepressants: -0.349 (-0.551 to -0.146); combinations of pharmacological agents: -0.518 (-0.757 to -0.279); glutamatergic medications: -0.289 (-0.478 to -0.1); psychological interventions: -0.396 (-0.563 to -0.229). No significant effect was found for first-generation antipsychotics: -0.531 (-1.104 to 0.041) and brain stimulation: -0.228 (-0.775 to 0.319). Effects of most treatments were not clinically meaningful as measured on Clinical Global Impression Severity Scale. CONCLUSIONS AND RELEVANCE: Although some statistically significant effects on negative symptoms were evident, none reached the threshold for clinically significant improvement.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Fusar‐Poli, P., Papanastasiou, E., Stahl, D. R., Rocchetti, M., Carpenter, W. T., Shergill, S. S., & McGuire, P. K. (2014). Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials. Schizophrenia Bulletin, 41(4), 892–899. https://doi.org/10.1093/schbul/sbu170
MLA 9
Fusar‐Poli, Paolo, et al. “Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials.” Schizophrenia Bulletin, vol. 41, no. 4, 2014, pp. 892–899. https://doi.org/10.1093/schbul/sbu170.
Chicago
Fusar‐Poli, Paolo, Evangelos Papanastasiou, Daniel R. Stahl, Matteo Rocchetti, William T. Carpenter, Sukhwinder Singh Shergill, and Philip K. McGuire. 2014. “Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials.” Schizophrenia Bulletin 41 (4): 892–899. https://doi.org/10.1093/schbul/sbu170.
Harvard
Fusar‐Poli, P. et al. (2014) ‘Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials’, Schizophrenia Bulletin, 41(4), pp. 892–899. doi:10.1093/schbul/sbu170.
IEEE
P. Fusar‐Poli et al., “Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials,” Schizophrenia Bulletin, vol. 41, no. 4, pp. 892–899, 2014, doi: 10.1093/schbul/sbu170.
BibTeX
@article{fusarpoli2014treatments,
title = {{Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials}},
author = {Fusar‐Poli, Paolo and Papanastasiou, Evangelos and Stahl, Daniel R. and Rocchetti, Matteo and Carpenter, William T. and Shergill, Sukhwinder Singh and McGuire, Philip K.},
journal = {Schizophrenia Bulletin},
year = {2014},
volume = {41},
number = {4},
pages = {892--899},
doi = {10.1093/schbul/sbu170},
url = {https://doi.org/10.1093/schbul/sbu170}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 64 | |
| 2018 | 60 | |
| 2019 | 61 | |
| 2020 | 95 | |
| 2021 | 74 | |
| 2022 | 89 | |
| 2023 | 64 | |
| 2024 | 65 | |
| 2025 | 81 | |
| 2026 | 61 |
Its field-weighted citation impact is 4.49: it has been cited 4.49 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- schizophrenia
- negative symptoms
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Fusar‐Poli, P., Papanastasiou, E., Stahl, D. R., Rocchetti, M., Carpenter, W. T., Shergill, S. S., & McGuire, P. K. (2014). Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials. Schizophrenia Bulletin, 41(4), 892–899. https://doi.org/10.1093/schbul/sbu170
How many times has this paper been cited?
782 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Schizophrenia Bulletin: sign in and open the PDF from this page.
Who wrote this paper?
Paolo Fusar‐Poli, Evangelos Papanastasiou, Daniel R. Stahl, Matteo Rocchetti, William T. Carpenter, Sukhwinder Singh Shergill, Philip K. McGuire.
What is the DOI of this paper?
10.1093/schbul/sbu170, permanently at https://doi.org/10.1093/schbul/sbu170. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.